MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2025)
MapLight Therapeutics recorded quarterly Non-Current Assets of $154.8 million in Q4 2025, up 1199.45% quarter-over-quarter from $11.9 million in Q3 2025, and up 593.92% year-over-year from $22.3 million in Q4 2024.
MapLight Therapeutics' Non-Current Assets history runs 2 years deep, the most recent figure standing at $154.8 million for Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 910.24 Mn |
| 10 | MapLight Therapeutics | 254.43 Mn | 254.43 Mn | - | 154.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.84 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Dec 31, 2024 | 22.31 Mn |